A detailed history of Acadian Asset Management LLC transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Acadian Asset Management LLC holds 3,965 shares of DGX stock, worth $543,561. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,965
Previous 5,751 31.06%
Holding current value
$543,561
Previous $786,000 21.88%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$137.09 - $137.09 $244,842 - $244,842
-1,786 Reduced 31.06%
3,965 $614,000
Q2 2024

Aug 06, 2024

SELL
$125.91 - $144.34 $809,727 - $928,250
-6,431 Reduced 52.79%
5,751 $786,000
Q4 2023

Feb 13, 2024

SELL
$120.62 - $141.12 $4.51 Million - $5.27 Million
-37,371 Reduced 75.42%
12,182 $1.68 Million
Q2 2023

Aug 07, 2023

BUY
$130.56 - $146.84 $5.72 Million - $6.44 Million
43,843 Added 767.83%
49,553 $6.96 Million
Q1 2023

May 11, 2023

SELL
$131.53 - $155.76 $3.23 Million - $3.83 Million
-24,586 Reduced 81.15%
5,710 $806,000
Q4 2022

Feb 14, 2023

BUY
$123.31 - $157.26 $1.34 Million - $1.7 Million
10,840 Added 55.72%
30,296 $4.74 Million
Q3 2022

Nov 14, 2022

SELL
$121.77 - $141.1 $1.68 Million - $1.95 Million
-13,819 Reduced 41.53%
19,456 $2.39 Million
Q3 2022

Nov 14, 2022

SELL
$121.77 - $141.1 $1.68 Million - $1.95 Million
-13,819 Reduced 41.53%
19,456 $2.39 Million
Q2 2022

Aug 09, 2022

SELL
$127.07 - $145.39 $11.1 Million - $12.6 Million
-86,966 Reduced 72.33%
33,275 $4.43 Million
Q1 2022

May 12, 2022

SELL
$129.09 - $164.35 $16.4 Million - $20.8 Million
-126,798 Reduced 51.33%
120,241 $16.5 Million
Q4 2021

Feb 10, 2022

SELL
$140.36 - $173.01 $15.5 Million - $19.1 Million
-110,562 Reduced 30.92%
247,039 $42.7 Million
Q3 2021

Nov 12, 2021

SELL
$132.95 - $158.0 $32 Million - $38 Million
-240,618 Reduced 40.22%
357,601 $51.9 Million
Q2 2021

Aug 11, 2021

BUY
$126.66 - $141.48 $3.06 Million - $3.42 Million
24,153 Added 4.21%
598,219 $79 Million
Q1 2021

May 11, 2021

BUY
$114.63 - $133.34 $12.4 Million - $14.5 Million
108,425 Added 23.29%
574,066 $73.7 Million
Q4 2020

Feb 11, 2021

SELL
$112.7 - $128.05 $26.3 Million - $29.9 Million
-233,400 Reduced 33.39%
465,641 $55.5 Million
Q3 2020

Nov 09, 2020

SELL
$107.05 - $130.01 $30.5 Million - $37.1 Million
-285,092 Reduced 28.97%
699,041 $80 Million
Q2 2020

Aug 12, 2020

SELL
$73.34 - $122.61 $2.46 Million - $4.11 Million
-33,482 Reduced 3.29%
984,133 $112 Million
Q1 2020

May 11, 2020

BUY
$75.14 - $115.68 $12.4 Million - $19.1 Million
164,909 Added 19.34%
1,017,615 $81.7 Million
Q4 2019

Feb 06, 2020

BUY
$100.29 - $107.99 $3.53 Million - $3.8 Million
35,180 Added 4.3%
852,706 $91.1 Million
Q3 2019

Nov 07, 2019

SELL
$97.85 - $107.42 $29.5 Million - $32.4 Million
-301,193 Reduced 26.92%
817,526 $87.5 Million
Q2 2019

Aug 08, 2019

SELL
$85.18 - $101.94 $25.1 Million - $30.1 Million
-294,960 Reduced 20.86%
1,118,719 $114 Million
Q1 2019

May 09, 2019

SELL
$80.68 - $89.92 $29.6 Million - $33 Million
-366,724 Reduced 20.6%
1,413,679 $127 Million
Q4 2018

Feb 07, 2019

BUY
$79.75 - $108.38 $10.9 Million - $14.8 Million
136,821 Added 8.32%
1,780,403 $148 Million
Q3 2018

Oct 30, 2018

SELL
$105.42 - $114.99 $2.84 Million - $3.1 Million
-26,927 Reduced 1.61%
1,643,582 $177 Million
Q2 2018

Jul 24, 2018

BUY
$97.35 - $113.14 $11.1 Million - $12.9 Million
113,584 Added 7.3%
1,670,509 $184 Million
Q1 2018

Apr 12, 2018

BUY
$96.42 - $107.88 $24.2 Million - $27.1 Million
250,958 Added 19.22%
1,556,925 $156 Million
Q4 2017

Jan 18, 2018

SELL
$90.86 - $100.24 $9.89 Million - $10.9 Million
-108,842 Reduced 7.69%
1,305,967 $129 Million
Q3 2017

Oct 13, 2017

BUY
$91.96 - $108.35 $130 Million - $153 Million
1,414,809
1,414,809 $132 Million

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.